目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Objectives
1.6.1 Objective 1
1.6.2 Objective 2

Chapter 2 Executive Summary
2.1 Personalized Medicine Market: Market Outlook

Chapter 3 Market Variables, Trends & Scope
3.1 Market Trends & Outlook
3.2 Trend Analysis
3.2.1 Product Trends
3.2.1.1 Personalized Medicine Diagnostics Trends
3.2.1.2 Personalized Medicine Therapeutics Trends
3.2.1.3 Personalized Medical Care Trends
3.2.1.4 Personalized Nutrition & Wellness Trends
3.3 Market Segmentation & Scope
3.4 Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Utility of human genome data for clinical research
3.4.1.1.1Targeted and personalized healthcare
3.4.1.2 Technological advancements to facilitate R&D for Personalized Medicine
3.4.1.2.1 Emergence of advanced genome editing techniques
3.4.1.2.2 Utility of novel databases for research
3.4.2 Market restraint analysis
3.4.2.1 Ethical issues and protection of individual’s genomic data
3.4.2.2 Limited access to human genome data and databases
3.4.3 Opportunity analysis
3.5 Impact of COVID - 19 Pandemic on Personalized Medicine Market
3.6 Penetration & Growth Prospect Mapping for Products, 2021
3.7 Business Environment Analysis
3.7.1 Personalized Medicine Market - Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.7.2 Porter’s Five Forces Analysis
3.8 Market Share Analysis
3.8.1 Company Size
3.8.2 Product portfolio
3.8.3 Strategic Initiatives
3.9 Competitive Landscape
3.9.1 Strategy Framework
3.9.2 Market Participation Categorization
3.9.2.1 New/ emerging entrants
3.9.2.2 Mature players & leaders

Chapter 4 Product Business Analysis
4.1 Personalized Medicine Diagnostics
4.1.1 Global Personalized Medicine Diagnostics Market, 2018 - 2030 (USD Billion)
4.1.2 Genetic Testing
4.1.2.1 Global Personalized Medicine Market for Genetic Testing, 2018 - 2030 (USD Billion)
4.1.3 Direct - To - Consumer (DTC) Testing
4.1.3.1 Global Personalized Medicine Market for Direct - To - Consumer (DTC) Testing, 2018 - 2030 (USD Billion)
4.1.4 Esoteric Lab Services
4.1.4.1 Global Personalized Medicine Market for Esoteric Lab Services, 2018 - 2030 (USD Billion)
4.1.5 Esoteric Lab Tests
4.1.5.1 Global Personalized Medicine Market for Esoteric Lab Services, 2018 - 2030 (USD Billion)
4.2 Personalized Medicine Therapeutics
4.2.1 Global Personalized Medicine TherapeuticsMarket, 2018 - 2030 (USD Billion)
4.2.2 Pharmaceuticals
4.1.2.1 Global Personalized Therapeutics Market for Pharmaceuticals, 2018 - 2030 (USD Billion)
4.1.3 Genomic Medicine
4.1.3.1 Global Personalized Therapeutics Market for Genomic Medicine, 2018 - 2030 (USD Billion)
4.1.4 Medical Devices
4.1.4.1 Global Personalized TherapeuticsMarket for Medical Devices, 2018 - 2030 (USD Billion)
4.3 Personalized Medical Care
4.2.1 Global Personalized Medical CareMarket, 2018 - 2030 (USD Billion)
4.2.2 Telemedicine
4.1.2.1 Global Personalized Medical Care Market for Telemedicine, 2018 - 2030 (USD Billion)
4.1.3 Health Information Technology
4.1.3.1 Global Personalized Medical Care Market for Health Information Technology, 2018 - 2030 (USD Billion)
4.3 Personalized Nutrition & Wellness
4.2.1 Global Personalized Nutrition & WellnessMarket, 2018 - 2030 (USD Billion)
4.2.2 Retail Nutrition
4.1.2.1 Global Nutrition & Wellness Market for Retail Nutrition, 2018 - 2030 (USD Billion)
4.1.3 Complementary & Alternative Medicine
4.1.3.1 Global Nutrition & Wellness Market for Complementary & Alternative Medicine, 2018 - 2030 (USD Billion)

Chapter 5 Regional Business Analysis
5.1Persoanlized Medicine Market: Regional Movement Analysis, 2021 & 2030
5.2 North America
5.2.1 North America market estimates and forecast, 2018 - 2030 (USD Billion)
5.2.2 U.S.
5.2.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
5.2.3 Canada
5.2.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
5.3 Europe
5.3.1 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
5.3.2 Germany
5.3.2.1 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
5.3.3 U.K.
5.3.3.1 U.K. market estimates and forecast, 2018 - 2030 (USD Billion)
5.3.4 France
5.3.4.1 France market estimates and forecast, 2018 - 2030 (USD Billion)
5.3.5 Italy
5.3.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
5.3.6 Spain
5.3.6.1 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
5.4 Asia Pacific
5.4.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Billion)
5.4.2 Japan
5.4.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Billion)
5.4.3 China
5.4.3.1 China market estimates and forecast, 2018 - 2030 (USD Billion)
5.4.4 India
5.4.4.1 India market estimates and forecast, 2018 - 2030 (USD Billion)
5.4.5 Australia
5.4.5.1 Australia market estimates and forecast, 2018 - 2030 (USD Billion)
5.4.6 South Korea
5.4.6.1 South Korea market estimates and forecast, 2018 - 2030 (USD Billion)
5.5 Latin America (LATAM)
5.5.1 Latin America market estimates and forecast, 2018 - 2030 (USD Billion)
5.5.2 Brazil
5.5.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
5.5.3 Mexico
5.5.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
5.5.4 Argentina
5.5.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
5.6 Middle East and Africa (MEA)
5.6.1 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Billion)
5.6.2 South Africa
5.6.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Billion)
5.6.3 Saudi Arabia
5.6.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion)
5.6.4 UAE
5.6.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 6 Company Profiles
6.1 Company Profiles
6.1.1 GE Healthcare
6.1.1.1 Company Overview
6.1.1.2 Financial Performance
6.1.1.3 Product Benchmarking
6.1.1.4 Strategic Initiatives
6.1.2 Illumina, Inc.
6.1.2.1 Company Overview
6.1.2.2 Financial Performance
6.1.2.3 Product Benchmarking
6.1.2.4 Strategic Initiatives
6.1.3 ASURAGEN, INC.
6.1.3.1 Company Overview
6.1.3.2 Financial Performance
6.1.3.3 Product Benchmarking
6.1.3.4 Strategic Initiatives
6.1.4 Abbott
6.1.4.1 Company Overview
6.1.4.2 Financial Performance
6.1.4.3 Product Benchmarking
6.1.4.4 Strategic Initiatives
6.1.5 Dako A/S
6.1.5.1 Company Overview
6.1.5.2 Financial Performance
6.1.5.3 Product Benchmarking
6.1.5.4 Strategic Initiatives
6.1.6 Exact Sciences Corporation
6.1.6.1 Company Overview
6.1.6.1 Financial Performance
6.1.6.2 Product Benchmarking
6.1.6.3 Strategic Initiatives
6.1.7 Cepheid, Inc. (Danaher Corporation)
6.1.7.1 Company Overview
6.1.7.2 Financial Performance
6.1.7.3 Product Benchmarking
6.1.7.4 Strategic Initiatives
6.1.8 Decode Genetics, Inc.
6.1.8.1 Company Overview
6.1.8.2 Financial Performance
6.1.8.3 Product Benchmarking
6.1.8.4 Strategic Initiatives
6.1.9 QIAGEN, Inc.
6.1.9.1 Company Overview
6.1.9.2 Financial Performance
6.1.9.3 Product Benchmarking
6.1.9.4 Strategic Initiatives
6.1.10 Exagen Inc.
6.1.10.1 Company Overview
6.1.10.2 Financial Performance
6.1.10.3 Product Benchmarking
6.1.10.4 Strategic Initiatives
6.1.11 Precision Biologics
6.1.11.1 Company Overview
6.1.11.2 Financial Performance
6.1.11.3 Product Benchmarking
6.1.11.4 Strategic Initiatives
6.1.12 Celera Diagnostics LLC
6.1.12.1 Company Overview
6.1.12.2 Financial Performance
6.1.12.3 Product Benchmarking
6.1.12.4 Strategic Initiatives
6.1.13 Biogen
6.1.13.1 Company Overview
6.1.13.2 Financial Performance
6.1.13.3 Product Benchmarking
6.1.13.4 Strategic Initiatives
6.1.14 Genelex (Invitae Corporation)
6.1.14.1 Company Overview
6.1.14.2 Financial Performance
6.1.14.3 Product Benchmarking
6.1.14.4 Strategic Initiatives
6.1.15 International Business Machines Corporation (IBM)
6.1.15.1 Company Overview
6.1.15.2 Product Benchmarking
6.1.15.3 Strategic Initiatives
6.1.16 Genentech, Inc.
6.1.16.1 Company Overview
6.1.16.2 Financial Performance
6.1.16.3 Product Benchmarking
6.1.16.4 Strategic Initiatives
6.1.17 23 andMe, Inc.
6.1.17.1 Company Overview
6.1.17.2 Financial Performance
6.1.17.3 Product Benchmarking
6.1.17.4 Strategic Initiatives

List of Tables
TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Incidence of Diseases
TABLE 4 Global Personalized Medicine Market, By Region, 2018 - 2030 (USD Billion)
TABLE 5 Global Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 6 North America Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)
TABLE 7 North America Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 8 U.S. Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 9 Canada Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 10 Europe Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)
TABLE 11 Europe Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 12 Germany Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 13 U.K. Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 14 France Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 15 Italy Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 16 Spain Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 17 Asia Pacific Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)
TABLE 18 Asia Pacific Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 19 Japan Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 20 China Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 21 India Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 22 South Korea Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 23 Australia Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 24 Latin America Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)
TABLE 25 Latin America Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 26 Brazil Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 27 Mexico Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 28 Argentina Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 29 Middle East & Africa Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)
TABLE 30 Middle East & Africa Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 31 Saudi Arabia Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 32 South Africa Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)
TABLE 33 UAE Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)

List of Figures
FIG. 1 Information Procurement
FIG. 2 Primary Research Pattern
FIG. 3 Market Research Approaches
FIG. 4 Value Chain - Based Sizing & Forecasting
FIG. 5 Market Formulation & Validation
FIG. 6 Personalized Medicine Market Segmentation
FIG. 7 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 8 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 9 Market Challenge Relevance Analysis (Current & Future Impact)
FIG. 10 Penetration & Growth Prospect Mapping
FIG. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
FIG. 12 Porter’s Five Forces Analysis
FIG. 13 Market Penetration Vs Growth Prospect Mapping, 2021
FIG. 14 Personalized MedicineMarket: Product Key Takeaways
FIG. 15 Global Personalized Medicine Market, for Product, 2018 - 2030 (USD Billion)
FIG. 16 Global Personalized Medicine Market, for Diagnostics, 2018 - 2030 (USD Billion)
FIG. 17 Global Personalized Medicine Market, for Genetic Testing, 2018 - 2030 (USD Billion)
FIG. 18 Global Personalized Medicine Market, for Direct - To - Consumer (DTC) Testing, 2018 - 2030 (USD Billion)
FIG. 19 Global Personalized Medicine Market, for Esoteric Lab Services, 2018 - 2030 (USD Billion)
FIG. 20 Global Personalized Medicine Market, for Esoteric Lab Tests, 2018 - 2030 (USD Billion)
FIG. 21 Global Personalized Medicine Market, for Therapeutics, 2018 - 2030 (USD Billion)
FIG. 22 Global Personalized Medicine Market, for Pharmaceutical, 2018 - 2030 (USD Billion)
FIG. 23 Global Personalized Medicine Market, for Genomic Medicine, 2018 - 2030 (USD Billion)
FIG. 24 Global Personalized MedicineMarket, for Medical Devices, 2018 - 2030 (USD Billion)
FIG. 25 Global Personalized Medicine Market, for Personalized Medical Care, 2018 - 2030 (USD Billion)
FIG. 26 Global Personalized Medicine Market, for Telemedicine, 2018 - 2030 (USD Billion)
FIG. 27 Global Personalized Medicine Market, for Health Information Technology, 2018 - 2030 (USD Billion)
FIG. 28 Global Personalized Medicine Market, for Personalized Nutrition & Wellness, 2018 - 2030 (USD Billion)
FIG. 29 Global Personalized Medicine Market, for Retail Nutrition, 2018 - 2030 (USD Billion)
FIG. 30 Global Personalized Medicine Market, for Complementary & Alternative Medicine, 2018 - 2030 (USD Billion)
FIG. 31 Regional Outlook, 2021 & 2030
FIG. 32 North America Personalized MedicineMarket, 2018 - 2030 (USD Billion)
FIG. 33 U.S.Personalized MedicineMarket, 2018 - 2030 (USD Billion)
FIG. 34 Canada Personalized MedicineMarket, 2018 - 2030 (USD Billion)
FIG. 35 Europe Personalized MedicineMarket, 2018 - 2030 (USD Billion)
FIG. 36 Germany Personalized MedicineMarket, 2018 - 2030 (USD Billion)
FIG. 37 U.K. Personalized MedicineMarket, 2018 - 2030 (USD Billion)
FIG. 38 France Personalized MedicineMarket, 2018 - 2030 (USD Billion)
FIG. 39 Italy Personalized MedicineMarket, 2018 - 2030 (USD Billion)
FIG. 40 Spain Personalized MedicineMarket, 2018 - 2030 (USD Billion)
FIG. 41 Asia Pacific Personalized MedicineMarket, 2018 - 2030 (USD Billion)
FIG. 42 Japan Personalized MedicineMarket, 2018 - 2030 (USD Billion)
FIG. 43 China Personalized MedicineMarket, 2018 - 2030 (USD Billion)
FIG. 44 India Personalized MedicineMarket, 2018 - 2030 (USD Billion)
FIG. 45 Australia Personalized MedicineMarket, 2018 - 2030 (USD Billion)
FIG. 46 South Korea Personalized MedicineMarket, 2018 - 2030 (USD Billion)
FIG. 47 Latin America Personalized MedicineMarket, 2018 - 2030 (USD Billion)
FIG. 48 Brazil Personalized MedicineMarket, 2018 - 2030 (USD Billion)
FIG. 49 Mexico Personalized MedicineMarket, 2018 - 2030 (USD Billion)
FIG. 50 Argentina Personalized MedicineMarket, 2018 - 2030 (USD Billion)
FIG. 51 Middle East and Africa Personalized MedicineMarket, 2018 - 2030 (USD Billion)
FIG. 52 South Africa Personalized MedicineMarket, 2018 - 2030 (USD Billion)
FIG. 53 Saudi Arabia Personalized Medicine Market, 2018 - 2030 (USD Billion)
FIG. 54 UAE Personalized MedicineMarket, 2018 - 2030 (USD Billion)